Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasir Y Elamin

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Cancers|June 10, 2023
New Actions on Actionable Mutations in Lung CancersXiuning Le, Yasir Y Elamin, Jianjun Zhang
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|October 19, 2014
Immune effects of bevacizumab: killing two birds with one stoneYasir Y Elamin, Shereen Rafee, Sinead Toomey, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|August 24, 2015
Thymidine Phosphorylase in Cancer; Enemy or Friend?Yasir Y Elamin, Shereen Rafee, Nemer Osman, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 15, 2013
Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experienceNemer Osman, Yasir Y Elamin, Shereen Rafee, et al.
Tumori|March 7, 2015
Neoadjuvant crizotinib in advanced inflammatory myofibroblastic tumour with ALK gene rearrangementShereen Rafee, Yasir Y Elamin, Eimear Joyce, et al.
International Journal of Molecular Sciences|July 14, 2023
Protein Tyrosine Phosphatase Non-Receptor 11 (<i>PTPN11</i>/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)Cathy E Richards, Yasir Y Elamin, Aoife Carr, et al.
International Journal of Molecular Sciences|April 30, 2026
RETRACTED: Richards et al. Protein Tyrosine Phosphatase Non-Receptor 11 (<i>PTPN11</i>/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC). <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 10545Cathy E Richards, Yasir Y Elamin, Aoife Carr, et al.
BJU International|January 28, 2020
Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertionsRussell W Madison, Sumati V Gupta, Yasir Y Elamin, et al.
Cold Spring Harbor Molecular Case Studies|January 5, 2017
ALK: a tyrosine kinase target for cancer therapyVijaykumar R Holla, Yasir Y Elamin, Ann Marie Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLCSonia A Patel, Monique B Nilsson, Yan Yang, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Cancers|June 10, 2023
New Actions on Actionable Mutations in Lung CancersXiuning Le, Yasir Y Elamin, Jianjun Zhang
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|October 19, 2014
Immune effects of bevacizumab: killing two birds with one stoneYasir Y Elamin, Shereen Rafee, Sinead Toomey, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|August 24, 2015
Thymidine Phosphorylase in Cancer; Enemy or Friend?Yasir Y Elamin, Shereen Rafee, Nemer Osman, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 15, 2013
Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experienceNemer Osman, Yasir Y Elamin, Shereen Rafee, et al.
Tumori|March 7, 2015
Neoadjuvant crizotinib in advanced inflammatory myofibroblastic tumour with ALK gene rearrangementShereen Rafee, Yasir Y Elamin, Eimear Joyce, et al.
International Journal of Molecular Sciences|July 14, 2023
Protein Tyrosine Phosphatase Non-Receptor 11 (<i>PTPN11</i>/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)Cathy E Richards, Yasir Y Elamin, Aoife Carr, et al.
International Journal of Molecular Sciences|April 30, 2026
RETRACTED: Richards et al. Protein Tyrosine Phosphatase Non-Receptor 11 (<i>PTPN11</i>/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC). <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 10545Cathy E Richards, Yasir Y Elamin, Aoife Carr, et al.
BJU International|January 28, 2020
Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertionsRussell W Madison, Sumati V Gupta, Yasir Y Elamin, et al.
Cold Spring Harbor Molecular Case Studies|January 5, 2017
ALK: a tyrosine kinase target for cancer therapyVijaykumar R Holla, Yasir Y Elamin, Ann Marie Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLCSonia A Patel, Monique B Nilsson, Yan Yang, et al.
Pageof 5